These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29555328)

  • 1. Blend of organic acids and medium chain fatty acids prevents the inflammatory response and intestinal barrier dysfunction in mice challenged with enterohemorrhagic Escherichia coli O157:H7.
    Wang J; Lu J; Xie X; Xiong J; Huang N; Wei H; Jiang S; Peng J
    Int Immunopharmacol; 2018 May; 58():64-71. PubMed ID: 29555328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathelicidin-WA Improves Intestinal Epithelial Barrier Function and Enhances Host Defense against Enterohemorrhagic Escherichia coli O157:H7 Infection.
    Yi H; Hu W; Chen S; Lu Z; Wang Y
    J Immunol; 2017 Feb; 198(4):1696-1705. PubMed ID: 28062699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathelicidin- derived PR39 protects enterohemorrhagic Escherichia coli O157:H7 challenged mice by improving epithelial function and balancing the microbiota in the intestine.
    Haiwen Z; Rui H; Bingxi Z; Qingfeng G; Beibei W; Jifeng Z; Xuemei W; Kebang W
    Sci Rep; 2019 Jul; 9(1):9456. PubMed ID: 31263234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota.
    Bao CL; Liu SZ; Shang ZD; Liu YJ; Wang J; Zhang WX; Dong B; Cao YH
    J Appl Microbiol; 2021 Jul; 131(1):470-484. PubMed ID: 33289241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Administration of Bovine Lactoferrin-Derived Lactoferricin (Lfcin) B Could Attenuate Enterohemorrhagic Escherichia coli O157:H7 Induced Intestinal Disease through Improving Intestinal Barrier Function and Microbiota.
    Haiwen Z; Rui H; Bingxi Z; Qingfeng G; Jifeng Z; Xuemei W; Beibei W
    J Agric Food Chem; 2019 Apr; 67(14):3932-3945. PubMed ID: 30892034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cathelicidin LL-37 exerts amelioration effects against EHEC O157:H7 infection regarding inflammation, enteric dysbacteriosis, and impairment of gut barrier function.
    Fang X; Nong K; Wang Z; Jin Y; Gao F; Zeng Q; Wang X; Zhang H
    Peptides; 2023 Jan; 159():170903. PubMed ID: 36370932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lcn2 deficiency accelerates the infection of Escherichia coli O157:H7 by disrupting the intestinal barrier function.
    Zhang K; Chen J; Liang L; Wang Z; Xiong Q; Yu H; Du H
    Microb Pathog; 2023 Dec; 185():106435. PubMed ID: 37931825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterohemorrhagic E. coli alters murine intestinal epithelial tight junction protein expression and barrier function in a Shiga toxin independent manner.
    Roxas JL; Koutsouris A; Bellmeyer A; Tesfay S; Royan S; Falzari K; Harris A; Cheng H; Rhee KJ; Hecht G
    Lab Invest; 2010 Aug; 90(8):1152-68. PubMed ID: 20479715
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Liu D; Li C; Cao T; Lv X; Yue Y; Li S; Cheng Y; Liu F; Huo G; Li B
    Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Cecropin-LL37 Hybrid Peptide Protects Mice Against EHEC Infection-Mediated Changes in Gut Microbiota, Intestinal Inflammation, and Impairment of Mucosal Barrier Functions.
    Wei X; Zhang L; Zhang R; Koci M; Si D; Ahmad B; Cheng J; Wang J; Aihemaiti M; Zhang M
    Front Immunol; 2020; 11():1361. PubMed ID: 32695115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability.
    Howe KL; Reardon C; Wang A; Nazli A; McKay DM
    Am J Pathol; 2005 Dec; 167(6):1587-97. PubMed ID: 16314472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation.
    Assa A; Vong L; Pinnell LJ; Avitzur N; Johnson-Henry KC; Sherman PM
    J Infect Dis; 2014 Oct; 210(8):1296-305. PubMed ID: 24755435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A blend of formic acid, benzoic acid, and tributyrin alleviates ETEC K88-induced intestinal barrier dysfunction by regulating intestinal inflammation and gut microbiota in a murine model.
    Chen J; Xia Y; Hu Y; Zhao X; You J; Zou T
    Int Immunopharmacol; 2023 Jan; 114():109538. PubMed ID: 36502593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hemorrhagic coli pilus (HCP) of Escherichia coli O157:H7 is an inducer of proinflammatory cytokine secretion in intestinal epithelial cells.
    Ledesma MA; Ochoa SA; Cruz A; Rocha-Ramírez LM; Mas-Oliva J; Eslava CA; Girón JA; Xicohtencatl-Cortes J
    PLoS One; 2010 Aug; 5(8):e12127. PubMed ID: 20711431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of
    Bonvicini F; Pagnotta E; Punzo A; Calabria D; Simoni P; Mirasoli M; Passerini N; Bertoni S; Ugolini L; Lazzeri L; Gentilomi GA; Caliceti C; Roda A
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33036498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The postbiotic HM0539 from
    Zhang H; Gao J; He X; Gong Z; Wan Y; Hu T; Li Y; Cao H
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Feb; 40(2):211-218. PubMed ID: 32376527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic administration of the recombinant antimicrobial peptide microcin J25 effectively enhances host defenses against gut inflammation and epithelial barrier injury induced by enterotoxigenic Escherichia coli infection.
    Yu H; Wang Y; Zeng X; Cai S; Wang G; Liu L; Huang S; Li N; Liu H; Ding X; Song Q; Qiao S
    FASEB J; 2020 Jan; 34(1):1018-1037. PubMed ID: 31914603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function.
    Johnson-Henry KC; Donato KA; Shen-Tu G; Gordanpour M; Sherman PM
    Infect Immun; 2008 Apr; 76(4):1340-8. PubMed ID: 18227169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caprylic acid and nonanoic acid upregulate endogenous host defense peptides to enhance intestinal epithelial immunological barrier function via histone deacetylase inhibition.
    Wang J; Huang N; Xiong J; Wei H; Jiang S; Peng J
    Int Immunopharmacol; 2018 Dec; 65():303-311. PubMed ID: 30342347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary genistein supplementation improves intestinal mucosal barrier function in Escherichia coli O78-challenged broilers.
    Zhang M; Kou J; Wu Y; Wang M; Zhou X; Yang Y; Wu Z
    J Nutr Biochem; 2020 Mar; 77():108267. PubMed ID: 32000135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.